Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Radiodermatitis 1

Interventions

dimethicone 1Petrolatum 1Norepinephrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Radiodermatitis × Norepinephrine × Clear all
NCT01544504 2012-05-28

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

ProCertus BioPharm, Inc

Phase 1/2 Withdrawn

Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡